Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new Oxford Sparks animation travels inside our body, shrinking down to a cellular level, to see how amazing our immune system really is. The role of the immune system is to protect us against disease or invading threats, such as viruses, bacteria and parasites. But how does it do that?

The role of the immune system is to protect us against disease or invading threats, such as viruses, bacteria and parasites. But how does it do that?

When looking for new treatments for human disease, one possible strategy is to use observations made in the clinic and work back to the cellular causes. In the Davis and Cornall labs, we follow the opposite strategy - we  seek new treatments for human disease by first trying to understand how healthy cells function, focusing on the processes most likely to impact on disease.

As our video “The immune system - the battle within” shows, there is no process more interesting to investigate than the immune system (or at least we think so!). The immune system is the defence mechanism within our bodies - it normally protects us from foreign pathogens and other threats such as cancer but it is also the root cause of many debilitating diseases, such as diabetes and rheumatoid arthritis.

Watch the Oxford Sparks animation to find out more (Oxford Sparks website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.